Contact Alex

Speaking Engagements

  

There has been growing interest in targeting kinases such as JAK, TYK, IRAK, SIK, CDK, MEK, ERK, RTK, PLK, PI3K, ALK, MAPK, GSK, LRRK, and more for their role in neurodegeneration, inflammation, cancer, autoimmune, and other disorders. However, targeting kinases selectively and specifically has always been a challenge, as they intersect so many pat

25-25 September 2023
  

While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s conference on Proteomics-Driven Drug Discovery focuses on the use of mass spectrometry, biochemical,

26-27 September 2023